-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Bolsa de Comercio de Buenos Aires-
Johnson & JohnsonBörse Börse FrankfurtISIN US4781601046EURSymbol JNJ
-
Johnson & JohnsonBörse Börse StuttgartEURSymbol JNJ
-
Johnson & JohnsonBörse Börse MünchenEURSymbol JNJ
-
Johnson & JohnsonBörse Börse BerlinEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Xetra FrankfurtEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Gettex System der Börse MünchenEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol JNJ
-
JOHNSON & JOHNSONBörse Quotrix System der Börse DüsseldorfEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Börse DüsseldorfEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Börse HamburgEURSymbol JNJ
-
USDJohnson & JohnsonBörse SGO
-
USDJohnson & JohnsonBörse BUE
-
Johnson & JohnsonBörse Bolsa de Comercio de Buenos Aires
-
Johnson & JohnsonBörse Bolsa de Comercio de Buenos Aires
-
Johnson & JohnsonBörse Bolsa de Comercio de Buenos Aires
-
Johnson & JohnsonBörse Bolsa Mexicana de Valore Mexiko-Stadt
-
Johnson & JohnsonBörse SSE
-
Marktkapitalisierung
99.567.000.000
Mitarbeiter
141.700
Aktionärsstruktur der Johnson & Johnson
Portrait der Johnson & Johnson Aktie
Das Unternehmen Johnson & Johnson aus USA beschäftigt 141.700 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Drogerie & Kosmetik, Biotechnologie, Pharma tätig.
Johnson & Johnson ist in ungefähr 18 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter UBS ETF (IE) Factor MSCI USA Quality UCITS ETF (hedged to CHF) A-acc gewichtet Johnson & Johnson mit 4,34% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Johnson & Johnson Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Johnson & Johnson am höchsten gewichtet ist Insgesamt in 18 ETFs enthalten
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
3.033 News & Informationen zur Johnson & Johnson Aktie
Big Pharma Stocks Hit Hard by Drug Price Proposals
GuruFocus Article or News written by Barry Cohen and the topic is about: Declines could present a good buying opportunity
Pfizer Gets a Small Boost From Vaccine Trial Announcement
GuruFocus Article or News written by Graham Griffin and the topic is about: Clinical trials show positive results for kids under 11
U.S. administers 386.2 million doses of COVID-19 vaccines
U.S. administers 386.2 million doses of COVID-19 vaccines – CDC
Pfizer says low dose of its COVID-19 vaccine works in younger children
COVID-19 cases among children are becoming more common, indicating the need for vaccines, Pfizer CEO said.
Stock Market Today With Jim Cramer: Prepare to Buy What's Working
Jim Cramer discusses China's property developer Evergrande and other catalysts to Monday's selloff.
ROUNDUP 3: USA wollen geimpfte Ausländer ab November wieder einreisen lassen
ROUNDUP 3: USA wollen geimpfte Ausländer ab November wieder einreisen lassen | Nachricht | finanzen.net
India set to get first J&J COVID vaccine doses in October, says source
NEW DELHI — India expects to get its first Johnson & Johnson COVID-19 vaccine doses from next month, filled and finished in India by a partner of the U.S.…
10 Pharmaceutical Stocks to Buy Today According to Tiger Cub Billionaire Lee Ainslie
In this article, we will take a look at 10 pharmaceutical stocks to buy today according to Tiger Cub Billionaire Lee Ainslie.
FDA advisory committee approves booster for individuals 65 and older and others at high risk for COVID-19
Vote does not go far enough in addressing boosters for healthcare workers, some committee members say.
Moderna’s Vaccine, More Effective Than Pfizer’s and J&J’s At Preventing Hospitalizations
The Covid vaccine by Moderna Inc (NASDAQ:MRNA) is the most effective at preventing hospitalization, when compared to Pfizer’s (NYSE:PFE)
Vietnam to buy 10 million Covid-19 vaccine doses from Cuba
The Vietnamese government has agreed to use the provision of “choosing contractors in special cases” to purchase 10 million Abdala vaccine doses from Cuba. – VnExpress International
+++Coronavirus-Update+++ – Corona: BAG meldet 4032 neue Infektionen seit Freitag – Ab heute gelten neue Einreiseregeln für die Schweiz – Österreich geht mit 3G-Regel für Skipisten in die Wintersportsa
Erfahren Sie hier alle aktuellen Entwicklungen zur Coronavirus-Krise, zusammengetragen von der Redaktion von cash.ch.
Pfizer says data show COVID-19 vaccine is safe, effective in children 5-11
Pfizer and BioNTech announced on Monday that studies show that their COVID-19 vaccine is safe and produces a significant antibody response against the coronavirus disease in children between 5 and 11 years old.
Dow Futures Slump As China Evergrande, Growth Worries Rattle Global Stocks
U.S. equity futures slumped lower amid the steepest pre-market declines of the year Monday as the twin concerns of slowing growth and accelerating coronavirus infections gripped global markets ahead of a crucial Federal Reserve policy meeting later this week.
Why don't Covid-19 shots last longer?
“Researchers have calculated a key number – threshold of protection – for other vaccines. Covid-19’s is still a mystery.”
Axsome Therapeutics Stock Rises 36% In A Month But Will The Rally Continue?
A couple of months back we discussed that Axsome Therapeutics stock is likely to rebound after it fell nearly 20% in a month following the U.S. FDA’s decision to pull the breakthrough therapy designation of AXS-12, the company’s drug used for the treatment of narcolepsy…
Adagio Therapeutics Provides COVID-19 Antibody Program Updates as well as Business Highlights and Second Quarter 2021 Financial Results
Adagio Therapeutics Provides COVID-19 Antibody Program Updates as well as Business Highlights and Second Quarter 2021 Financial Results
GlobeNewswire
September 20, 2021
New Data Supporting Potential of ADG20 for Both the Treatment and Prevention of COVID-19 to be Presented at IDWeek 2021 WALTHAM, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics,…
Key data on US J&J, Moderna COVID-19 boosters 'weeks away,' Fauci says
U.S. health regulators already have begun to consider a third dose of the Pfizer/BioNTech vaccine.
Key data on U.S. J&J, Moderna COVID-19 boosters 'weeks away,' Fauci says By Reuters
Key data on U.S. J&J, Moderna COVID-19 boosters 'weeks away,' Fauci says
Key data on U.S. J&J, Moderna COVID-19 boosters 'weeks away,' Fauci says
WASHINGTON — Data needed to determine the advisability of booster shots of the Moderna Inc and Johnson & Johnson COVID-19 vaccines is just weeks away,…
Johnson & Johnson : RYBREVANT® (amivantamab-vmjw) Provides Higher Activity and Longer Duration of Response When Used in Combination with Lazertinib in Patients with Advanced EGFR-Mutant Non-Small Cell
New analysis from CHRYSALIS study presented at the ESMO Annual Congress 2021 supports simultaneously targeting the extracellular and catalytic domains of EGFR
September… | September 19, 2021
Johnson & Johnson : New Data on RYBREVANT® (amivantamab-vmjw) in Combination with Lazertinib Show Early Activity in Patients with Non-Small Cell Lung Cancer Whose Disease Has Progressed After Both Osi
CHRYSALIS-2 findings presented at ESMO Annual Congress 2021 suggest that RYBREVANT® and lazertinib combination has encouraging anti-tumor activity in this population that has exhausted… | September 19, 2021
Fauci Warns Not To Get Booster Shot Before Approval — Which Could Be A Few Weeks Away For Some
Even though the FDA didn’t approve Pfizer boosters for the general public now, Fauci suggested the guidance on booster shots will “evolve” as more data comes in.
Presseschau vom Wochenende 38 (18./19. September)
Nachfolgend eine Auswahl von Artikeln zu wirtschaftsrelevanten Themen aus der Presse vom Wochenende:
Fauci defends FDA panel, says it didn't make a mistake rejecting booster Covid shots for all Americans
The comments from Fauci come as the FDA advisory committee voted on Friday against giving third shots of Pfizer's vaccine to the general U.S. population.
World leaders return to U.N. with focus on pandemic, climate
World leaders are returning to the United Nations in New York this week with a focus on boosting efforts to fight both climate change and the COVID-19 pandemic.
World leaders return to UN with focus on COVID-19 pandemic, climate change
As the coronavirus still rages amid an inequitable vaccine rollout, about a third of the 193 UN states are planning to again send videos
World leaders return to U.N. with focus on pandemic, climate By Reuters
World leaders return to U.N. with focus on pandemic, climate
Mosques in Perlis to open fully from Wednesday
KANGAR: Perlis is allowing all mosques to be fully opened from Wednesday (Sept 22) with strict adherence to the standard operating procedures (SOP). R…
Die Schlagzeilen der Sonntagspresse vom Sonntag, 19. September 2021
Ein geplatztes Treffen zwischen Frankreichs Staatschef Emmanuel Macron und Bundespräsident Guy Parmelin, heikle Dienstwagenfahrten von Bundesrat Alain Berset und die Schlüsselfiguren der sogenannten “Freiheitstrychlern…
10 Healthcare Stocks to Buy According to Mario Gabelli
In this article, we discuss the 10 healthcare stocks to buy according to Mario Gabelli.
FDA And Pfizer Need A Covid-19 Reality Booster
Yesterday’s FDA Vaccines and Related Biological Products (VRBPAC) meeting on the Pfizer booster was so problematic as to make a reasonable person wonder whether our vaccine strategy was ever about science.
Bis zu 700.000€ : Diese Biotech-Unternehmen zahlen höchsten Gehälter
Spitzenreiter ist das US-Pharmaunternehmen TG Therapeutics, das im Schnitt seinen Angestellten 701.000 Dollar im Jahr 2020 zahlte.
FDA Panel Backs Pfizer Booster for 65 and Up, Rejects Broad Use
(Bloomberg) — Two members of an expert advisory committee questioned the need for a broad approval of a booster dose of the Pfizer Inc.-BioNTech SE Covid-19 vaccine at this time.
US FDA panel backs booster shot for elderly, high risk groups
Read more about US FDA panel backs booster shot for elderly, high risk groups on Business Standard. A US FDA advisory panel has endorsed a booster shot of Pfizer-BioNTech Covid-19 vaccine six months after full inoculation in people above 65 years and for individuals at high risk for severe disease
Vietnam approves emergency use of Cuba's Covid vaccine
The Ministry of Health on Friday granted emergency approval of Cuba’s Abdala Covid-19 vaccine. – VnExpress International
WHO emergency use authorisation to Covaxin delayed till October 5
Read more about WHO emergency use authorisation to Covaxin delayed till October 5 on Business Standard. World Health Organisation's (WHO) approval for the emergency use authorisation to COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to be delayed till October 5.
Some Long Islanders are willing to be fired rather than get vaccinated
With their vaccination deadlines fast approaching, some Long Islanders said they are willing to lose their jobs and even change careers before complying with workplace mandates. For some, resistance t
Moderna Covid Vaccine More Effective Than Others In Preventing Hospitalization, CDC Finds
All three coronavirus vaccines offer strong protection against hospitalization, the CDC said Friday — but one vaccine appeared to outpace the others.
J&J-Aktie schließt in Rot: Experten sehen gehäufte Impfdurchbrüche bei Impfstoff von Johnson & Johnson
Experten und Behörden fallen vermehrte Impfdurchbrüche beim Impfstoff von Johnson & Johnson auf. 17.09.2021